Hepatitis B Care Pathway In The United Arab Emirates: Current Situation, Gaps And Actions
White Paper
Jan 17, 2020

Hepatitis B virus (HBV) infection remains a worldwide public health problem with an estimated prevalence of 468 million cases in 2016 according to the Global Burden of Disease Study (GBD2016). In the last major review of the epidemiology and management of HBV in the Middle East, a trend was observed of moving from high-to-intermediate to low-to-intermediate endemicity.

Our latest whitepaper explores the current situation of the HBV care pathway in UAE, identifies gaps / barriers therein and recommends comprehensive initiatives to be undertaken to improve the overall situation.